Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.
暂无分享,去创建一个
Marc Parmentier | Jean-Marie Vanderwinden | Matthias Mack | Josef Cihak | M. Parmentier | M. Mack | S. Marullo | C. Blanpain | G. Vassart | J. Vanderwinden | M. Stangassinger | J. Cihak | E. Le Poul | V. Wittamer | Cédric Blanpain | Gilbert Vassart | Valérie Wittamer | Emmanuel Le Poul | Hassan Issafras | Manfred Stangassinger | Stefano Marullo | Detlef Schlndorff | H. Issafras | Detlef Schlndorff
[1] C. Martínez-A,et al. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. , 1997, Journal of immunology.
[2] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[3] J. Wess. G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] C. Martínez-A,et al. Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection , 2000, EMBO reports.
[5] G. Winter,et al. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Jenness,et al. Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. , 2000, Molecular biology of the cell.
[7] M. Bouvier,et al. Structural and functional aspects of G protein-coupled receptor oligomerization. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[8] D. Kwon,et al. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins. , 1998, Virology.
[9] C. Mackay,et al. Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding , 1997, The Journal of experimental medicine.
[10] C. Martínez-A,et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Sodroski,et al. A Tyrosine-Rich Region in the N Terminus of CCR5 Is Important for Human Immunodeficiency Virus Type 1 Entry and Mediates an Association between gp120 and CCR5 , 1998, Journal of Virology.
[12] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[13] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[14] Peter Kopp,et al. Resistance to TSH , 1999 .
[15] E. Prossnitz,et al. Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved “DRY” Sequence* , 2000, Journal of Biological Chemistry.
[16] R. Doms,et al. Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[17] A. Hanyaloglu,et al. Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.
[18] Marc Parmentier,et al. Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity , 1996, Cell.
[19] C. Browning,et al. Signalling by CXC‐chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPγS binding induced by IL‐8 and GROα , 1999, British journal of pharmacology.
[20] H. Brühl,et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.
[21] O. Nishimura,et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] Nancy Sullivan,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[23] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[24] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[25] M. Oppermann,et al. Differential Effects of CC Chemokines on CC Chemokine Receptor 5 (CCR5) Phosphorylation and Identification of Phosphorylation Sites on the CCR5 Carboxyl Terminus* , 1999, The Journal of Biological Chemistry.
[26] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[27] M. Mack,et al. Endocytosis and Recycling of the HIV Coreceptor Ccr5 , 2000, The Journal of cell biology.
[28] L. Miller,et al. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. , 1997, Molecular pharmacology.
[29] C. Martínez-A,et al. Chemokine control of HIV-1 infection , 1999, Nature.
[30] G Vassart,et al. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.
[31] K. Blumer,et al. G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.
[32] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[33] H. Lother,et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.
[34] M. Mack,et al. Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.
[35] G Vassart,et al. Multiple Charged and Aromatic Residues in CCR5 Amino-terminal Domain Are Involved in High Affinity Binding of Both Chemokines and HIV-1 Env Protein* , 1999, The Journal of Biological Chemistry.
[36] R. Doms,et al. Multiple nonfunctional alleles of CCR5 are frequent in various human populations. , 2000, Blood.
[37] M. Caron,et al. Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features. , 1999, Molecular pharmacology.
[38] A. Tashjian,et al. A Receptor-G Protein Coupling-independent Step in the Internalization of the Thyrotropin-releasing Hormone Receptor* , 1997, The Journal of Biological Chemistry.
[39] Marc Parmentier,et al. The Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity* , 1997, The Journal of Biological Chemistry.
[40] John P. Moore,et al. New targets for inhibitors of HIV-1 replication , 2000, Nature Reviews Molecular Cell Biology.
[41] L. Hunyady,et al. Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction. , 1994, The Journal of biological chemistry.
[42] H. Lother,et al. Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.
[43] Michel Bouvier,et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .
[44] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[45] M. Mack,et al. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Lameh,et al. Antibody to Epitope Tag Induces Internalization of Human Muscarinic Subtype 1 Receptor , 1998, Journal of Neurochemistry.
[47] Jean Salamero,et al. HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.
[48] Kuan-Teh Jeang,et al. Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.
[49] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[50] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[51] F. Sánchez‐Madrid,et al. Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.
[52] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[53] F. Sánchez‐Madrid,et al. Leukocyte polarization in cell migration and immune interactions , 1999, The EMBO journal.
[54] Robert J. Lefkowitz,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[55] William C. Olson,et al. Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5 , 1999, Journal of Virology.
[56] M. Locati,et al. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. , 1997, Virology.
[57] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[58] Gerda E Breitwieser,et al. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. , 2004, Circulation research.
[59] Christopher J. Evans,et al. Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.
[60] C. Strader,et al. Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor. , 1990, Molecular pharmacology.
[61] T. Schwartz,et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.
[62] H. Guy,et al. Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.
[63] L. Lopalco,et al. CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1 , 2000, The Journal of Immunology.
[64] S. Karnik,et al. Agonist-induced Phosphorylation of the Angiotensin II (AT1A) Receptor Requires Generation of a Conformation That Is Distinct from the Inositol Phosphate-signaling State* , 2000, The Journal of Biological Chemistry.
[65] C. Martínez-A,et al. Membrane raft microdomains mediate front–rear polarity in migrating cells , 1999, The EMBO journal.
[66] G Vassart,et al. Extracellular Cysteines of CCR5 Are Required for Chemokine Binding, but Dispensable for HIV-1 Coreceptor Activity* , 1999, The Journal of Biological Chemistry.
[67] U. Kumar,et al. Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.